Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AMT 101

Next Previous
Drug Profile

AMT 101

Alternative Names: AMT-101

Latest Information Update: 01 Jan 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Applied Molecular Transport
  • Developer Cyclo Therapeutics
  • Class Anti-inflammatories; Antirheumatics; Cytokines; Interleukins; Recombinant fusion proteins
  • Mechanism of Action Interleukin 10 replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Pouchitis
  • New Molecular Entity Yes
  • Available For Licensing Yes - Pouchitis

Highest Development Phases

  • Suspended Inflammatory bowel diseases; Pouchitis; Rheumatoid arthritis; Ulcerative colitis

Most Recent Events

  • 27 Dec 2023 Applied Molecular Transport has merged with Cyclo Therapeutics to form Cyclo Therapeutics
  • 29 Mar 2023 AMT 101 is available for licensing as of 27 Mar 2023. www.appliedmt.com
  • 27 Mar 2023 Suspended - Phase-I for Ulcerative colitis (Treatment-experienced) in Moldova, Georgia, Ukraine, Germany

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top